Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Sep 05, 2003
Other
Other Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Sep 05, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 --
Sep 12, 2003
President, Oncology Division
President, Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Sep 12, 2003
VP,Finance, Strategic Planning
VP,Finance, Strategic Planning Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 12, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 215,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jun 10, 2004
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 2,000 $6.75
Jun 21, 2004
President Oncology Division
President Oncology Division Open market or private purchase of non-derivative or derivative security 400 $5.40
Jun 21, 2004
President Oncology Division
President Oncology Division Open market or private purchase of non-derivative or derivative security 200 $5.39
Jun 21, 2004
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,000 $5.40
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.